kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Research advances in the treatment
Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS Screening and Profiling Services Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





